(Total Views: 1482)
Posted On: 04/17/2017 6:29:29 PM
Post# of 93
Well, I will step back and just
watch this one after looking at
the 10-K.
I can't predict a thing about its business model.
Compounding pharmacies for humans and animals.
They are going to create 3 subsidiaries.
Their share structure remains solid though.
As of April 14, 2017, the registrant had
17,213,894 shares outstanding
watch this one after looking at
the 10-K.
I can't predict a thing about its business model.
Compounding pharmacies for humans and animals.
They are going to create 3 subsidiaries.
Their share structure remains solid though.
As of April 14, 2017, the registrant had
17,213,894 shares outstanding
(0)
(0)
